Protein biomarkers in exhaled air to help detect lung cancer early
February 3rd, 2011 - 5:14 pm ICT by ANIWashington, Feb 3 (ANI): The earlier a tumour can be detected, the greater the chance of healing the patient. But early diagnosis is often difficult in many cases.
In its initial stages, the tumour-related complaints resemble chronic inflammatory reactions.
Now, researchers at the Fraunhofer Institute for Cell Therapy and Immunology IZI and the University Clinic in Leipzig are developing a new diagnostics platform which could detect the illness in its early stages - protein biomarkers in exhaled air that divulge the presence of pathological cells in the lung.
They want to produce a first prototype that can then be further developed into a diagnostic tool that can be used in practice.
“Since 2006, working with the working groups of Professor Hubert Wirtz and Professor Ulrich Sack of the University Clinic, we first identified various biomarkers that are particularly well-suited for the identification of lung-cancer cells,” said Jorg Lehmann, head of the Cell Engineering/GLP Unit at IZI.
“The main difficulty lies in finding a reliable way to distinguish cancer from chronic inflammatory disease,” he added.
The researchers have developed a laboratory method for reliably identifying biomarkers specific to lung cancer in special samples of exhaled air.
To accomplish this, the patient must breathe into a piece of equipment for roughly 20 minutes. The exhaled breath condensate is then evaporated.
Biomarkers are detected by means of special antibodies that recognize substances such as the protein VEGF.
This protein is responsible for stimulating the growth of new blood vessels.
This laboratory method is still too ‘elaborate and expensive’ for normal everyday use, said Lehmann.
In their new testing platform, the researchers have actually applied two new developments: in addition to the method enlisting protein biomarkers to identify cancer cells, they also make use of the antibody specially developed for this procedure.
This way, within just a few years, every physician investigating a suspicion of lung cancer can use the diagnostic platform right in his or her practice to test whether there really is a tumour and quickly initiate treatment. (ANI)
- Four novel biomarkers that may help diagnose asthma, COPD identified - Mar 12, 2011
- Unique 'smell print' in patients' breath may help improve lung cancer diagnosis - Aug 03, 2009
- Novel non-invasive tests could help in early detection of cancer - May 04, 2011
- Observing cells in 3-D could reveal new cancer targets - Jun 22, 2010
- New 'nanodrug' can attack breast cancer cells from the inside out - Mar 30, 2011
- Blood protein in lung cancer may help improve diagnosis, treatment - Mar 03, 2011
- Potential biomarkers for predicting colon cancer spread - Mar 04, 2010
- Now, a tiny white bread mint like capsule to track cancer in the body - Mar 16, 2011
- Now, blood tests can detect Alzheimer's disease before symptoms occur - Feb 12, 2011
- New protein analysis technique may help in early diagnosis of lung cancer - Dec 03, 2010
- Life work culminates in testing of cancer therapy in humans - Mar 24, 2011
- Microsponges from seaweed may help diagnose diseases quickly - Feb 10, 2011
- New technique diagnoses brain cancers non-invasively - Jan 29, 2012
- Genetic change helps lung tumors spread to other parts of the body - Apr 07, 2011
- 'Low oxygen levels drive cancer growth' - May 06, 2012
Tags: cell engineering, chronic inflammatory disease, condensate, diagnostic tool, everyday use, fraunhofer institute, inflammatory reactions, initial stages, izi, jorg lehmann, laboratory method, lung cancer, lung cancer cells, new blood, procedur, professor ulrich, protein biomarkers, tumour, wirtz, working groups